Trichomoniasis
ICD-10 A59 is a billable code used to indicate a diagnosis of trichomoniasis.
Trichomoniasis is a sexually transmitted infection (STI) caused by the protozoan parasite Trichomonas vaginalis. It primarily affects the urogenital tract in both men and women, although women are more likely to experience symptoms. In women, symptoms may include vaginal discharge, itching, and discomfort during intercourse or urination. Men may experience urethritis, which can manifest as discharge and burning during urination. The infection is often asymptomatic, particularly in men, which can lead to unrecognized transmission. Diagnosis is typically made through laboratory testing of vaginal secretions or urine. Treatment involves the use of antibiotics, most commonly metronidazole or tinidazole, which are effective in eradicating the infection. It is crucial to treat sexual partners simultaneously to prevent reinfection. Contact tracing is an essential component of managing trichomoniasis, as it helps to identify and treat individuals who may have been exposed to the infection, thereby reducing transmission rates. Regular screening for STIs, including trichomoniasis, is recommended for sexually active individuals, particularly those with multiple partners or those who engage in unprotected sex.
Detailed patient history, including sexual history and symptomatology.
Diagnosis and management of STIs, including trichomoniasis.
Ensure documentation reflects the need for partner treatment and follow-up.
Documentation of gynecological exams, lab results, and treatment plans.
Routine STI screening in pregnant women or symptomatic patients.
Consideration of pregnancy-related implications and treatment safety.
Used when laboratory confirmation of trichomoniasis is needed.
Document the reason for testing and patient symptoms.
Infectious disease specialists may order this test more frequently.
The primary treatment for trichomoniasis is metronidazole or tinidazole, which are both effective in eradicating the infection.
